[Administration of a new hypotensive agent 2-(2,6-dichlorphenylamino) imidazoline chlorhydrate in the treatment of essential arterial hypertension].
D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D001795:Blood Pressure Determination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D012110:Reserpine / Q000627:therapeutic use; D014642:Vanilmandelic Acid / Q000652:urine; D014882:Water-Electrolyte Balance
D000959:Antihypertensive Agents; D007093:Imidazoles; D014642:Vanilmandelic Acid; D012110:Reserpine
Impiego di un nuovo ipotensivo, il cloridrato di 2-(2,6-diclorofenilamino)-imidazolina, nel trattamento dell'ipertensione arteriosa essenziale.